𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development, preparation, and testing of VAQTA®, a highly purified hepatitis A vaccine

✍ Scribed by A. Hagen; J. Aunins; P. DePhillips; C. B. Oswald; J. P. Hennessey Jr.; J. Lewis; M. Armstrong; C. Oliver; C. Orella; B. Buckland; R. Sitrin


Publisher
Springer
Year
2000
Tongue
English
Weight
240 KB
Volume
23
Category
Article
ISSN
1615-7605

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Preparation and evaluation of a zonal pu
✍ Reuven Levy; Dr. Zichria Zakay-Rones 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract A highly purified influenza vaccine was prepared on a large scale. The inactivated whole virus vaccine fulfills the requirements of the National Institutes of Health, Bethesda, for influenza A and B vaccines. The three strains of influenza virus, A/England/321/77, B/Hong Kong/8/73, and

Preparation of a highly purified vaccine
✍ Franz X. Heinz; Christian Kunz; Hans Fauma 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract By the use of continuous‐flow zonal Ultracentrifugation, a highly purified, inactivated tick‐borne encephalitis (TBE) virus vaccine was prepared that contained almost exclusively TBE virus particles. The purity of this preparation was 90‐ to 100‐fold higher than that of a previously use

Immunogenicity and reactogenicity of a h
✍ Christian Kunz; Franz X. Heinz; Hanns Hofmann 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

## Abstract Immunogenicity and reactogenicity of a vaccine containing inactivated tick‐borne encephalitis vims prepared by continuous flow zonal ultracentrifugation were compared with those of a previously used, less purified vaccine. Antibody response as measured by hemagglutination inhibition (HI

Inactivation of 1015 chimpanzee-infectio
✍ Dr. P. N. Lelie; H. W. Reesink; J. Niessen; B. Brotman; A. M. Prince 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of